These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 26033180)

  • 21. Response to Denosumab in 2 Children With Recurrent Giant Cell Tumor of the Bone With Pulmonary Metastasis.
    Reddy K; Ramirez L; Kukreja K; Venkatramani R
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e215-e218. PubMed ID: 31714440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Local Recurrence in Giant-Cell Tumor of Bone Treated by Neoadjuvant Denosumab.
    Chinder PS; Hindiskere S; Doddarangappa S; Pal U
    Clin Orthop Surg; 2019 Sep; 11(3):352-360. PubMed ID: 31475058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Denosumab in giant cell tumour of bone in the pelvis and sacrum: Long-term therapy or bone resection?
    Sambri A; Medellin MR; Errani C; Campanacci L; Fujiwara T; Donati D; Parry M; Grimer R
    J Orthop Sci; 2020 May; 25(3):513-519. PubMed ID: 31155442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Denosumab for Bone Giant Cell Tumor of the Distal Radius.
    Tsukamoto S; Mavrogenis AF; Tanzi P; Leone G; Ciani G; Righi A; Akahane M; Honoki K; Tanaka Y; Donati DM; Errani C
    Orthopedics; 2020 Sep; 43(5):284-291. PubMed ID: 32745221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610.
    Urakawa H; Mizusawa J; Tanaka K; Eba J; Hiraga H; Kawai A; Nishida Y; Hosaka M; Iwamoto Y; Fukuda H; Ozaki T
    Jpn J Clin Oncol; 2019 Apr; 49(4):379-382. PubMed ID: 30796832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone.
    Sano K; Suehara Y; Okubo T; Sasa K; Kurihara T; Akaike K; Kubota D; Torigoe T; Hasegawa N; Ishii M; Nakamura Y; Kim Y; Takagi T; Kaneko K; Hayashi T; Saito T
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020929786. PubMed ID: 32539628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current concepts in the treatment of giant cell tumour of bone.
    van der Heijden L; Dijkstra S; van de Sande M; Gelderblom H
    Curr Opin Oncol; 2020 Jul; 32(4):332-338. PubMed ID: 32541321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone.
    Lipplaa A; Dijkstra S; Gelderblom H
    Curr Opin Oncol; 2019 Jul; 31(4):329-335. PubMed ID: 30844887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
    Rekhi B; Verma V; Gulia A; Jambhekar NA; Desai S; Juvekar SL; Bajpai J; Puri A
    Pathol Oncol Res; 2017 Jan; 23(1):157-164. PubMed ID: 27722984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone].
    Sørensen AL; Hansen RL; Jørgensen PH
    Ugeskr Laeger; 2016 Sep; 178(36):. PubMed ID: 27593237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative denosumab treatment in patients with giant cell bone tumors in limbs: A retrospective study using propensity score matching.
    Huang Y; Xu M; Wang B; Zhao Z; Lin T; Huang G; Yin J; Xie X; Shen J; Zou C
    Cancer Med; 2023 Jun; 12(11):12041-12049. PubMed ID: 37212474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone?
    Hindiskere S; Errani C; Doddarangappa S; Ramaswamy V; Rai M; Chinder PS
    Clin Orthop Relat Res; 2020 Nov; 478(11):2522-2533. PubMed ID: 32401001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort.
    Boye K; Jebsen NL; Zaikova O; Knobel H; Løndalen AM; Trovik CS; Monge OR; Hall KS
    Acta Oncol; 2017 Mar; 56(3):479-483. PubMed ID: 28105885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of intraoperative magnetic resonance imaging for giant cell tumor of bone after denosumab treatment: a pilot study.
    Furuta T; Kubo T; Sakuda T; Saito T; Kurisu K; Muragaki Y; Adachi N
    Acta Radiol; 2022 Feb; 63(2):176-181. PubMed ID: 33517664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
    Scoccianti G; Totti F; Scorianz M; Baldi G; Roselli G; Beltrami G; Franchi A; Capanna R; Campanacci DA
    Clin Orthop Relat Res; 2018 Sep; 476(9):1783-1790. PubMed ID: 30778015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial.
    Lipplaa A; Kroep JR; van der Heijden L; Jutte PC; Hogendoorn PCW; Dijkstra S; Gelderblom H
    Oncologist; 2019 Jul; 24(7):889-e421. PubMed ID: 31040253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultra-Short Course of Neo-Adjuvant Denosumab for Nerve-Sparing Surgery for Giant Cell Tumor of Bone in Sacrum.
    Liang H; Liu X; Yang Y; Guo W; Yang R; Tang X; Yan T; Li Y; Tang S; Li D; Qu H; Dong S; Ji T; Du Z; Zang J
    Spine (Phila Pa 1976); 2022 May; 47(9):691-701. PubMed ID: 34961753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study.
    Urakawa H; Yonemoto T; Matsumoto S; Takagi T; Asanuma K; Watanuki M; Takemoto A; Naka N; Matsumoto Y; Kawai A; Kunisada T; Kubo T; Emori M; Hiraga H; Hatano H; Tsukushi S; Nishida Y; Akisue T; Morii T; Takahashi M; Nagano A; Yoshikawa H; Sato K; Kawano M; Hiraoka K; Tanaka K; Iwamoto Y; Ozaki T
    World J Surg Oncol; 2018 Aug; 16(1):160. PubMed ID: 30089488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative Denosumab Therapy Against Giant Cell Tumor of Bone is Associated with an Increased Risk of Local Recurrence After Curettage Surgery.
    Asano N; Saito M; Kobayashi E; Morii T; Kikuta K; Watanabe I; Anazawa U; Takeuchi K; Suzuki Y; Susa M; Nishimoto K; Ishii R; Miyazaki N; Mrioka H; Kawai A; Horiuchi K; Nakayama R
    Ann Surg Oncol; 2022 Jun; 29(6):3992-4000. PubMed ID: 35175454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature.
    Luengo-Alonso G; Mellado-Romero M; Shemesh S; Ramos-Pascua L; Pretell-Mazzini J
    Arch Orthop Trauma Surg; 2019 Oct; 139(10):1339-1349. PubMed ID: 30877429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.